ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 656

ERdj5 Function Is Involved in Inflammatory Manifestations of Sjögren’s Syndrome in the Salivary Glands

Eirini Apostolou1, Petros Moustardas2, Takao Iwawaki3, Giannis Spyrou2 and Athanasios G. Tzioufas4, 1Pathophysiology, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece, 2Clinical and Experimental Medicine, Division of Microbiology and Molecular Medicine, Linköping University, Linköping, Sweden, 3Life Science, Division of Cell Medicine, Medical Research Institute, Kanazawa Medical University, Ishikawa, Japan, 4School of Medicine, Pathophysiology Department, National and Kapodistrian University of Athens, Athens, Greece

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Sjogren's syndrome

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 13, 2016

Title: Sjögren's Syndrome - Poster I: Translational Science

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:  Sjögren’s syndrome is a chronic autoimmune disorder that affects mainly the exocrine glands. The initiation and causative agents are still unknown. Endoplasmic Reticulum (ER) stress proteins have been suggested to participate in autoimmune and inflammatory responses, either by acting as autoantigens themselves, or by modulating factors in inflammatory responses.ERdj5 is anER-resident chaperone proteinwith a disulfide reductase activityand is required for the translocationof misfolded proteins across the ERfor proteasomaldegradation. In this study we sought to investigate the role of ERdj5 in the salivary glands, in associationwith inflammation and autoimmunity.

Methods:  In situexpression of ERdj5 was studied immunohistochemically in minor salivary gland tissues (MSG) from primarySjögren’s Syndrome (SS)-patients and non-SS sicca-complaining controls. Submaxillary glands and sera from both male and female ERdj5-knockoutmice andage-matched wild types were collected at 6,34 and 52 weeks of age. Tissue samples were analyzed microscopically, while sera were screened for anti-nuclear antibodies(ANAs).

Results:  Human MSGs expressed ERdj5,with higher stain intensity in MSGs of SS patients with severe inflammatory lesions.Mice deficient in ERdj5 spontaneously developed SS-like inflammation in submaxillary glands and ANAssystemically. Inflammation was characterized by T and B infiltrating lymphocytes. Notably, female ERdj5-knockout mice developed severe chronic periductal inflammation in contrast to the much milder phenotype found in male littermates.

Conclusion:  Salivary glands of ERdj5-knockout mice resemble the pathologic lesions of human Sjögren’s syndrome whereasERdj5 wasinduced in MSGs of SS patients. Our findings suggest a critical connection betweenthe function of the ER stress chaperone protein ERdj5 andautoimmune inflammatory responses in the salivary glands.


Disclosure: E. Apostolou, None; P. Moustardas, None; T. Iwawaki, None; G. Spyrou, None; A. G. Tzioufas, None.

To cite this abstract in AMA style:

Apostolou E, Moustardas P, Iwawaki T, Spyrou G, Tzioufas AG. ERdj5 Function Is Involved in Inflammatory Manifestations of Sjögren’s Syndrome in the Salivary Glands [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/erdj5-function-is-involved-in-inflammatory-manifestations-of-sjogrens-syndrome-in-the-salivary-glands/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/erdj5-function-is-involved-in-inflammatory-manifestations-of-sjogrens-syndrome-in-the-salivary-glands/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology